Music |
Video |
Movies |
Chart |
Show |
Christopher Cannon, ADA 2020: Results of the Phase III VERTIS-CV Trial (Touch Medical Media) View | |
Christopher Cannon, MD: VERTIS-CV and Ertugliflozin (HCPLive) View | |
Researcher comment: The VERTIS-CV trial | Chris Cannon (Medicine Matters diabetes) View | |
ADA 2020: Findings from EMPA-REG OUTCOME trial — Dr Muthiah Vaduganathan (Radcliffe Cardiology) View | |
Expert commentary: The VERTIS-CV trial | Francesco Giorgino (Medicine Matters diabetes) View | |
Cardiology Countdown | COURAGE, Health Literacy and STEMI Care (American College of Cardiology Video Archive) View | |
Diabetes Medications - SGLT 2 inhibitors - Ertugliflozin (Steglatro) (Dr. Andras Fazakas) View | |
EMPEROR-Reduced: Time for a change in the HF guidelines | Miles Fisher (Medicine Matters diabetes) View | |
ADA TV - Day 5 Highlights (WebsEdgeMedicine) View | |
Sean Pittock, EAN 2020 – Phase 3 PREVENT Study Insights in Neuromyelitis Optica Spectrum Disorder (Touch Medical Media) View |